Nasopharyngeal carcinoma in the young

Martin P. Berry, Charles R. Smith, Thomas C. Brown, R. Derek T. Jenkin*, Walter D. Rider

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    51 Citations (Scopus)


    This study reviewed 25 patients with nasopharyngeal carcinoma who were less than 30 years of age at diagnosis. Lymphoepithelionna was the histological diagnosis in all but 3. The anatomical extent of disease was described using the TNM system. Local bone destruction was present in 10 patients at diagnosis; cervical nodes were clinically positive in 88 % of patients of which 54 % were bilateral. All were treated with radical irradiation using a variety of techniques and doses. No patient received adjuvant chemotherapy. Overall survival was 70 % at 5 years and 57 % at 10 years from diagnosis. There were 5 relapses at the primary site, 2 in cervical nodes and 8 in bone or lung. Primary site relapse was not demonstrated to be dependant on T group or radiation dose, but likely related to inadequacy of original treatment volume. Distant metastases at first relapse correlated with advanced T and N and were the principal obstacle to successful treatment. Adjuvant chemotherapy is suggested as an important target for further study.

    Original languageEnglish
    Pages (from-to)415-421
    Number of pages7
    JournalInternational Journal of Radiation Oncology, Biology, Physics
    Issue number4
    Publication statusPublished - 1980


    • Nasopharyngeal carcinoma (NPC
    • Radiation therapy


    Dive into the research topics of 'Nasopharyngeal carcinoma in the young'. Together they form a unique fingerprint.

    Cite this